Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.2%
Fri, 23 Aug 11:10

INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.2%Image source: DNY59/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has zoomed 5% and is presently trading at Rs 392.0.

Meanwhile, the BSE HEALTHCARE index is at 42,157.2 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 4.3%) and POLY MEDICURE (up 1.5%).

ERIS LIFESCIENCES (down 2.1%) and Cadila Healthcare (down 1.9%) are among the top losers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 159.5 to Rs 392.0, registering a gain of Rs 232.5 (up 145.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 42,157.2, registering a gain of 50.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.4%), Glenmark Pharma (up 117.2%) and GSK Pharma (up 110.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,123.0 (up 0.1%).

The top gainers among the BSE Sensex today are Tata Motors (up 1.7%) and M&M (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,842.6 (up 0.1%). Bajaj Auto and Tata Motors are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 81,123.0, registering a gain of 15,906.9 points (up 24.4%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 26.0.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.2%". Click here!